Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
NCT01691521
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
580
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
Mepolizumab IV
DRUG:
Mepolizumab SC
DRUG:
IV Placebo
DRUG:
SC Placebo
Sponsor
GlaxoSmithKline